samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Healthcare Best-in-class syringe components for high safety and functionality

Datwyler


We are pleased to announce that Datwyler has become a strategic partner for the supply of the rubber plungers for the Retrago syringes. This is the result of intensive team work to develop the customized design of four different plungers, provide samples for trials and prepare commercial production within shortest time lines possible.

Retrago. Automatically Retractable Syringe.

Retrago is an innovative reinvention of the syringe, implementing safety mechanisms promoting infection prevention and control. After a single injection, the Retrago syringe automatically retracts the exposed needle and prevents the re-use of the syringe.



RETRAGO syringes RETRAGO works like a normal syringe. After use, the needle retracts automatically.

Retrago is the first automatically retractable syringe that features Auto Disable (AD), Re-Use Prevention (RUP), and Sharp Injury Protection (SIP) safety mechanisms in one device.

The combination of these safety features not only protects patients, but also healthcare workers, waste management workers and the community from the risk of accidental needle stick injuries (NSI) and syringe re-use, potentially saving millions of lives.

Thanks to their unique design with a hole in the center, Datwyler‘s rubber plungers make an important contribution to ensuring that safety mechanisms function perfectly at all times. The Retrago technology is protected by a number of patents owned by Italian company P&P Patents and Technologies, which is focused on developing safety engineered medical devices.

UNAIDS Health Innovation Exchange (HIEx). RETRAGO was awarded by UNAIDS as one of the TOP 20 Global Health Innovations with the potential to deliver impact for countries reaching the Sustainable Development Goals (SDGs) and was launched during the 72th World Health Assembly from 21st to 23rd May 2019 at the UN Palais des Nations (Geneva, Switzerland) in the presence of 100 Ministers of Health.

This recognition, as well as the continued support of the Health Innovation Exchange team, has dramatically reduced the time to commercialize the innovation.

Improving the lives of patients – every day with every product. We share this aspiration with our Healthcare customers. We as an industrial supplier provide our customers with the necessary applications that not only complete their products, but also make them reliable. By meeting the high expectations of the Healthcare market, we make the future possible.
phone +41 41 875 11 23
email info@datwyler.com
web https://datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Catalent Announces Commercial Supply Agreement with Aurinia Pharmaceuticals for Newly-Approved LUPKYNIST Softgels

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it recently signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals.
More info >>


White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)


More info >>

Industry Events

MedTech Integrates 2021

22 June 2021, VIRTUAL CONFERENCE

Inspired by the success of the inaugural MedTech Integrates in last October, Life Science Integrates is delighted to announce the second Medtech Integrates conference. This one-day gathering of technology, diagnostics, devices and therapeutics organisations, as well as clinicians and regulators, provides a platform to discuss the major challenges impacting the MedTech sector.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement